PeterC.LimMD

Gynecologic Oncology

Medical Director Center of Hope Robotic and Minimally Invasive Pelvic Surgery Clinical Associate Professor University of Nevada School of Medicine

Join to view full profile

Dr. Lim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lim's full profile

Already have an account?

Office
5465 Reno Corporate Dr
Suite 100
Reno, NV 89511
Phone+1 775-327-4673

Fax+1 775-327-4611
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 1994 - 1997
University of Southern California/LAC+USC Medical CenterResidency, Obstetrics and Gynecology, 1990 - 1994
Drexel University College of MedicineClass of 1990

Certifications & Licensure

CA State Medical License 1991 - 2025
NV State Medical License 1998 - 2025
FL State Medical License 2018 - 2020
MN State Medical License 1994 - 1998
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
Active, not recruiting
Phase 3
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission Start of enrollment: 2010 Jul 01
Completed
Phase 2
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
Active, not recruiting
Phase 3
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 2
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2009 Nov 01
Terminated
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Start of enrollment: 2014 Feb 27
Active, not recruiting
Phase 2, Phase 3
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Start of enrollment: 2020 Jul 23
Completed
Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Platinum-doublet + Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (OnPrime, GOG-3076) Start of enrollment: 2022 Aug 31
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...
Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
24 citations
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients wi...
Lucy Gilbert, Ana Oaknin, Ursula A Matulonis, Gina M Mantia-Smaldone, Peter C Lim, Cesar M Castro, Diane Provencher, Sanaz Memarzadeh, Michael Method, Jiuzhou Wang, Ka...> ;Gynecologic Oncology. 2023 Mar 1
2 citations
Unconventional Obturator Artery Nutrient Branch: Image of an Anatomical Variation.
Benjamin L Bosse, Victoria J Palacios, Dustin W Dutcher, Emily J Etter, Peter C Lim, Caroline A Cobine, Gillian L Moritz> ;Diagnostics. 2022 Aug 21
12 citations
The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.
Mario M Leitao Jr, Qin C Zhou, Benny Brandt, Alexia Iasonos, Vasileios Sioulas, Katherine Lavigne Mager, Mark Shahin, Shaina Bruce, Destin R Black, Carrie G Kay, Meeli...> ;Gynecologic Oncology. 2022 Sep 1
85 citations
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.
Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo, Ana Oaknin, Giovanni Scambia, Domenica Lorusso, Gottfried E. Konecny, Susana Banerjee, Conleth G. Murphy, Janos L. T...> ;Annals of Oncology. 2021 Jun 1
4 citations
The early surgical period in robotic radical hysterectomy is related to the recurrence after surgery in stage IB cervical cancer.
Jiheum Paek, Peter C. Lim> ;International Journal of Medical Sciences. 2021 Jan 1
10 citations
Factors in the feasibility and safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma.
Tyson Matern, Elizabeth Kang, Peter C. Lim> ;Gynecologic Oncology. 2020 May 1
24 citations
The LACC Trial and Minimally Invasive Surgery in Cervical Cancer
Ignace Vergote, Javier F. Magrina, Vanna Zanagnolo, Paul M. Magtibay, Kristina A. Butler, Antonio Gil-Moreno, Berta Diaz Feijoo, Rainer Kimmig, Michel Canis, Nicholas ...> ;Journal of Minimally Invasive Gynecology. 2020 Feb 1
8 citations
Comparative analysis of genitourinary function after type C1 robotic nerve-sparing radical hysterectomy versus type C2 robotic radical hysterectomy
Jiheum Paek, Elizabeth Kang, Peter C. Lim> ;Surgical Oncology. 2019 Sep 1
9 citations
The Statement of the Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy for LACC Study.
Chyi-Long Lee, Kuan Gen Huang, Joo-Hyun Nam, Peter C. Lim, Felix Wong Wu Shun, Keen Whye Lee, Hiroyuki Kanao, Yoichi Aoki, Nobuhiro Takeshima, Wachyu Hadisaputra, Zhiq...> ;Gynecology and Minimally Invasive Therapy. 2019 Jul 1
2 citations
Robotic lower pelvic port placement for optimal upper paraaortic lymph node dissection
Jiheum Paek, Elizabeth Kang, Peter C. Lim> ;Journal of Gynecologic Oncology. 2018 Aug 30
Robotic surgery in gynecology.
Ngan, H. Y., Lim, P. C.> ;Best practice & research. Clinical obstetrics & gynaecology. 2017 Oct 11
6 citations
Robot-assisted gynaecological cancer surgery-complications and prevention.
Ka Yu Tse, Hextan Y.S. Ngan, Peter C. Lim> ;Best Practice & Research. Clinical Obstetrics & Gynaecology. 2017 Apr 23
3 citations
How to Prepare the Patient for Robotic Surgery: Before and During the Operation
Peter C. Lim, Elizabeth Kang> ;Best Practice & Research. Clinical Obstetrics & Gynaecology. 2017 Apr 27
54 citations
Multicenter analysis comparing robotic, open, laparoscopic, and vaginal hysterectomies performed by high-volume surgeons for benign indications
Peter C. Lim, John T. Crane, Eric J. English, Richard W. Farnam, Devin M. Garza, Marc L. Winter, Jerry L. Rozeboom> ;International Journal of Gynaecology and Obstetrics. 2016 Jun 1
Comparison of Robotic Vs Laparoscopic or Open Radical Hysterectomy: Five Year Survival for Surgical Treatment for Clinic Stage I Cervical Cancer.
Lim PC, Kang EY> ;J Minim Invasive Gynecol. 2015-01-01
12 citations
Comparative analysis of rectal dose parameters in image-guided high-dose-rate brachytherapy for cervical cancer with and without a rectal retractor.
Marc Gaudet, Peter Lim, Conrad Yuen, Susan Zhang, Ingrid Spadinger, Rustom Dubash, Christina Aquino-Parsons> ;Brachytherapy. 2014 May 1
61 citations
Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Bradley J. Monk, Joan L. Walker, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew P. Boente, Gini...> ;Journal of Clinical Oncology. 2014 Apr 20
116 citations
A comparative detail analysis of the learning curve and surgical outcome for robotic hysterectomy with lymphadenectomy versus laparoscopic hysterectomy with lymphadene...
Peter Lim, Elizabeth Kang, Do Hwan Park> ;Gynecologic Oncology. 2011 Mar 1
19 citations
Population-based treatment and outcomes of Stage I uterine serous carcinoma.
Louis J.M. van der Putten, Paul Hoskins, Anna V. Tinker, Peter Lim, Christina Aquino-Parsons, Janice S. Kwon> ;Gynecologic Oncology. 2014 Jan 1
26 citations
The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Leah Jutzi, Paul Hoskins, Peter Lim, Christina Aquino-Parsons, Anna V. Tinker, Janice S. Kwon> ;Gynecologic Oncology. 2013 Dec 1
4 citations
Preoperative radiotherapy for inoperable stage II endometrial cancer: insights into improving treatment and outcomes.
Marette Lee, Christina Aquino-Parsons, Paul Hoskins, Peter Lim, Janice S. Kwon> ;Journal of Obstetrics and Gynaecology Canada. 2013 Jul 1
5 citations
Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study
Peter H. Bartels, Francisco A.R. Garcia, Cornelia L. Trimble, James Kauderer, John P. Curtin, Peter Lim, Lisa M. Hess, Steven G. Silverberg, Richard J. Zaino, Michael ...> ;Gynecologic Oncology. 2012 Apr 1
19 citations
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer.
Alan N. Gordon, Michael Teneriello, Mike F. Janicek, Jeffrey F. Hines, Peter Lim, M. Dwight Chen, Luis Vaccarello, Howard D. Homesley, Scott McMeekin, Tiana L. Burkhol...> ;Gynecologic Oncology. 2011 Dec 1
10 citations
Robot-assisted total intracorporeal low anterior resection with primary anastomosis and radical dissection for treatment of stage IV endometriosis with bowel involveme...
Peter Lim, Elizabeth Kang, Do Hwan Park> ;Journal of Robotic Surgery. 2011 May 19
Join now to see all

Journal Articles

Factors in the Feasibility and Safety of Outpatient Robotic-Assisted Hysterectomy for Endometrial or Cervical Carcinoma
Peter Lim, MD, Gynecologic Oncology

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

Hospital Affiliations

Renown Regional Medical CenterReno, Nevada
Saint Mary's Regional Medical CenterReno, Nevada